103 related articles for article (PubMed ID: 9064893)
21. Phase I and II studies of toremifene.
Hamm JT
Oncology (Williston Park); 1997 May; 11(5 Suppl 4):19-22. PubMed ID: 9165502
[TBL] [Abstract][Full Text] [Related]
22. [A case of breast cancer with multiple bone metastases demonstrating complete remission with high-dose toremifene therapy].
Saito Y; Amano S; Kashio M; Abe H; Kuboi Y; Sakurai K; Aoki N; Hata S; Negishi N
Gan To Kagaku Ryoho; 2004 Jun; 31(6):911-4. PubMed ID: 15222111
[TBL] [Abstract][Full Text] [Related]
23. Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.
Marttunen MB; Cacciatore B; Hietanen P; Pyrhönen S; Tiitinen A; Wahlström T; Ylikorkala O
Br J Cancer; 2001 Apr; 84(7):897-902. PubMed ID: 11286468
[TBL] [Abstract][Full Text] [Related]
24. Phase II clinical trial of high-dose toremifene as primary hormone therapy in aromatase inhibitor-resistant breast cancer.
Ogata H; Okamoto Y; Arima Y; Fukushima H; Takeyama H; Yamashita A; Kinoshita M; Suzuki N; Sawada T; Koshida Y; Matsui A; Tachibana A; Nakayama H; Oishi Y; Nogi H; Uchida K
Gan To Kagaku Ryoho; 2013 Jun; 40(6):749-53. PubMed ID: 23863651
[TBL] [Abstract][Full Text] [Related]
25. [A study of the efficacy of high-dose toremifene in advanced and recurrent breast cancer].
Tokura H; Fujisaki M; Takahashi T; Takigawa Y; Onouchi S; Matsuda K; Hirata A
Gan To Kagaku Ryoho; 2012 Jul; 39(7):1071-3. PubMed ID: 22790041
[TBL] [Abstract][Full Text] [Related]
26. Dose-dependent hormonal effects of toremifene in postmenopausal breast cancer patients.
Ellmén J; Werner D; Hakulinen P; Keiling R; Fargeot P; Falkson G; Bezwoda WR
Cancer Chemother Pharmacol; 2000; 45(5):402-8. PubMed ID: 10803924
[TBL] [Abstract][Full Text] [Related]
27. [The results of a comparative clinical study of the antiestrogenic preparations toremifene and tamoxifen in locally advanced and disseminated breast cancer].
Konstantinova MM; Gershanovich MA
Vopr Onkol; 1990; 36(10):1182-6. PubMed ID: 2147527
[TBL] [Abstract][Full Text] [Related]
28. Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma.
Lee CP; Patel PM; Selby PJ; Hancock BW; Mak I; Pyle L; James MG; Beirne DA; Steeds S; A'Hern R; Gore ME; Eisen T
J Clin Oncol; 2006 Feb; 24(6):898-903. PubMed ID: 16484699
[TBL] [Abstract][Full Text] [Related]
29. Multi-cytokine therapy for advanced renal cell carcinoma: determination of the minimal effective dose.
Hamada I; Kato M; Okada K
Anticancer Res; 2002; 22(4):2429-36. PubMed ID: 12174939
[TBL] [Abstract][Full Text] [Related]
30. [A case of breast cancer patient of CAF (cyclophosphamide, adriamycin, 5-fluorouracil) resistant lung metastasis with remarkable response to reverse drug-resistance by toremifene].
Kusama M; Kaise H; Nakayama S; Ohta D; Aoki T; Koyanagi Y
Gan To Kagaku Ryoho; 1999 Jul; 26(8):1171-5. PubMed ID: 10431584
[TBL] [Abstract][Full Text] [Related]
31. Toremifene, a new agent for treatment of mastalgia: an open study.
Hamed H; Kotheri A; Beechey-Newman N; Fentiman IS
Int J Fertil Womens Med; 2004; 49(6):278-80. PubMed ID: 15751267
[TBL] [Abstract][Full Text] [Related]
32. Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2.
Lissoni P; Bordin V; Vaghi M; Fumagalli L; Bordoni A; Mengo S; Bucovec R; Fumagalli E; Malugani F; Ardizzoia A; Giani L; Gardani GS; Tancini G
Anticancer Res; 2002; 22(2B):1061-4. PubMed ID: 12168901
[TBL] [Abstract][Full Text] [Related]
33. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
[TBL] [Abstract][Full Text] [Related]
34. [Activity of toremifene plus mitomycin, vindesin and cisplatin regimen in unresectable non-small cell lung cancer].
Zhou CC; Zhang J; Zheng D; Lu MJ; Lu B; Xu JF
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):546-8. PubMed ID: 15388005
[TBL] [Abstract][Full Text] [Related]
35. Primary toremifene treatment for elderly postmenopausal women with breast cancer.
Hamada N; Ogawa Y; Nishioka A; Kariya S; Yoshida S
Oncol Rep; 2004 Feb; 11(2):365-70. PubMed ID: 14719069
[TBL] [Abstract][Full Text] [Related]
36. [A case of locally recurrent breast cancer in which phlebothrombosis of the right leg after hormonal therapy using a high dose of toremifene citrate].
Sakuta M; Sumiyama Y; Okamoto Y; Noto Y; Naka I; Kiribayashi T
Gan To Kagaku Ryoho; 2002 Jan; 29(1):115-8. PubMed ID: 11816466
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy of treatment with high-dose toremifene in patients with metastatic breast cancer resistant to aromatase inhibitor treatment].
Niikura N; Kimura M; Kobayashi Y; Asahara F; Hayashi K; Shibata S; Shintoku J
Gan To Kagaku Ryoho; 2009 Jun; 36(6):1013-6. PubMed ID: 19542727
[TBL] [Abstract][Full Text] [Related]
38. Prospective study of combined treatment with interferon-alpha and active vitamin D3 for Japanese patients with metastatic renal cell carcinoma.
Obara W; Mizutani Y; Oyama C; Akaza H; Ishii N; Kohri K; Namiki M; Okuyama A; Shima H; Yokoyama M; Shuin T; Miki T; Watanabe Y; Fujioka T
Int J Urol; 2008 Sep; 15(9):794-9. PubMed ID: 18651865
[TBL] [Abstract][Full Text] [Related]
39. Evolving role of toremifene in the adjuvant setting.
Holli K
Oncology (Williston Park); 1997 May; 11(5 Suppl 4):48-51. PubMed ID: 9165507
[TBL] [Abstract][Full Text] [Related]
40. Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial.
Price D; Stein B; Sieber P; Tutrone R; Bailen J; Goluboff E; Burzon D; Bostwick D; Steiner M
J Urol; 2006 Sep; 176(3):965-70; discussion 970-1. PubMed ID: 16890670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
